Literature DB >> 23062590

Presymptomatic late-onset Pompe disease identified by the dried blood spot test.

Matias Wagner1, Amina Chaouch, Juliane S Müller, Tuomo Polvikoski, Tracey A Willis, Anna Sarkozy, Michelle Eagle, Kate Bushby, Volker Straub, Hanns Lochmüller.   

Abstract

Pompe disease or glycogen storage disease type II is an autosomal recessive disorder caused by mutations in the GAA gene leading to muscle weakness. Here we describe a 15 years old presymptomatic patient with normal muscle MRI, unspecific muscle biopsy findings but abnormal acid maltase activity in a dried blood spot test. Sequencing the GAA-gene identified a heterozygous novel splice-site and a heterozygous previously described mutation. The case highlights the variability in clinical phenotype and difficulties to diagnose late-onset Pompe disease. Dried Blood Spot (DBS) might be the most sensitive tool to pick up mildly symptomatic patients.
Copyright © 2012 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23062590     DOI: 10.1016/j.nmd.2012.09.004

Source DB:  PubMed          Journal:  Neuromuscul Disord        ISSN: 0960-8966            Impact factor:   4.296


  3 in total

Review 1.  Diagnostic tools in late onset Pompe disease (LOPD).

Authors:  Olimpia Musumeci; Antonio Toscano
Journal:  Ann Transl Med       Date:  2019-07

2.  Highlighting intrafamilial clinical heterogeneity in late-onset Pompe disease.

Authors:  C Papadopoulos; G K Papadimas; H Michelakakis; E Kararizou; P Manta
Journal:  Mol Genet Metab Rep       Date:  2013-12-28

3.  Vacuolated PAS-Positive Lymphocytes on Blood Smear: An Easy Screening Tool and a Possible Biomarker for Monitoring Therapeutic Responses in Late Onset Pompe Disease (LOPD).

Authors:  Daniela Parisi; Olimpia Musumeci; Stefania Mondello; Teresa Brizzi; Rosaria Oteri; Alba Migliorato; Annamaria Ciranni; Tiziana E Mongini; Carmelo Rodolico; Giuseppe Vita; Antonio Toscano
Journal:  Front Neurol       Date:  2018-10-22       Impact factor: 4.003

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.